Quote:

---

... be able to have point of care, rapid diagnostics like we have with HIV... well you just get a drop of blood... you put it on a little cassette & it tells you if you are positive or negative... that's what companies are working on. [The] FDA working around the clock & the do have applications... we put out a call for applications... we've been talking about it from the podium... if you have an IGG assay... a rapid test... not ELISA... but you could have ELISA... I mean you could do the ELISA today because the original SARS antigens react very well to the current COVID-19 antibodies that people have... but we're really working on that both...so that we could have therapeutics that could be plasma driven ... so thank you... yes...

---